Bone Marrow TransplantationHepatic Veno-Occlusive DiseaseTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationAnemia, AplasticLeukemiaTransplantation ConditioningHematopoietic Stem Cell TransplantationBone MarrowBone Marrow CellsTransplantation, AutologousT-LymphocytesMice, Inbred C57BLHematopoietic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesTransplantation ChimeraGraft SurvivalTissue DonorsLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityTransplantation, IsogeneicImmunosuppressionCyclophosphamideTime FactorsBone Marrow DiseasesRecurrenceHematopoiesisHematologic NeoplasmsRadiation ChimeraKidney TransplantationCombined Modality TherapyLeukemia, Myeloid, AcuteGraft RejectionImmunosuppressive AgentsTreatment OutcomeRemission InductionTransplantation ImmunologyGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesStem Cell TransplantationLymphocyte DepletionBone Marrow ExaminationLeukocyte TransfusionLeukemia, MyeloidAcute DiseaseBone RemodelingSevere Combined ImmunodeficiencyBone Marrow NeoplasmsLymphoma, Non-HodgkinHeart TransplantationHLA AntigensChimeraGraft vs Tumor EffectMyelodysplastic SyndromesSurvival AnalysisColony-Forming Units AssayGraft vs Leukemia EffectHematologic DiseasesCyclosporinePostoperative ComplicationsActuarial AnalysisSpleenMice, Inbred BALB CLung TransplantationCytomegalovirus InfectionsNuclear FamilyLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsCell DifferentiationBone DensitySurvival RateFollow-Up StudiesLeukocyte CountPancytopeniaFlow CytometryGranulocyte Colony-Stimulating FactorCarmustineCytarabineOrgan TransplantationCells, CulturedMelphalanSkin TransplantationMultiple MyelomaLymphomaThymus GlandPeripheral Blood Stem Cell TransplantationAntigens, CD34EtoposideBone ResorptionAntilymphocyte SerumImmunophenotypingMice, KnockoutCord Blood Stem Cell TransplantationChimerism